Literature DB >> 18940580

Management of primary antibody deficiency with replacement therapy: summary of guidelines.

Chaim M Roifman1, Melvin Berger, Luigi D Notarangelo.   

Abstract

This article summarizes the guidelines for using replacement therapy in the management of patients who have primary antibody deficiency.

Entities:  

Mesh：

Year:  2008        PMID： 18940580     DOI： 10.1016/j.iac.2008.07.003

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN： 0889-8561            Impact factor:   3.479


  14 in total

Review 1.  Polyvalent immunoglobulins: challenges and perspectives.

Authors:  Isabella Quinti; Serelina Coluzzi; Federica Pulvirenti; Alessandro Prezzo; Gabriella Girelli
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

Review 2.  Comprehensive activities to increase recognition of primary immunodeficiency and access to immunoglobulin replacement therapy in Poland.

Authors:  Małgorzata Pac; Ewa Bernatowska
Journal:  Eur J Pediatr       Date:  2016-06-29       Impact factor: 3.183

Review 3.  New insights in the use of immunoglobulins for the management of immune deficiency (PID) patients.

Authors:  Gergely Krivan; Stephen Jolles; Eduardo Lopes Granados; Phillipe Paolantonacci; Rabye Ouaja; Ousmane Alfa Cissé; Ewa Bernatowska
Journal:  Am J Clin Exp Immunol       Date:  2017-11-01

4.  Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study.

Authors:  Isabella Quinti; Annarosa Soresina; Andrea Guerra; Roberto Rondelli; Giuseppe Spadaro; Carlo Agostini; Cinzia Milito; Amelia Chiara Trombetta; Marcella Visentini; Helene Martini; Alessandro Plebani; Massimo Fiorilli
Journal:  J Clin Immunol       Date:  2011-03-02       Impact factor: 8.317

5.  Serial Serum Immunoglobulin G (IgG) Trough Levels in Patients with X-linked Agammaglobulinemia on Replacement Therapy with Intravenous Immunoglobulin: Its Correlation with Infections in Indian Children.

Authors:  Deepti Suri; Sagar Bhattad; Avinash Sharma; Anju Gupta; Amit Rawat; Shobha Sehgal; Surjit Singh; Sudhir Gupta
Journal:  J Clin Immunol       Date:  2017-03-21       Impact factor: 8.317

Review 6.  An update on the use of immunoglobulin for the treatment of immunodeficiency disorders.

Authors:  Stephanie Albin; Charlotte Cunningham-Rundles
Journal:  Immunotherapy       Date:  2014       Impact factor: 4.196

Review 7.  Key aspects for successful immunoglobulin therapy of primary immunodeficiencies.

Authors:  C Cunningham-Rundles
Journal:  Clin Exp Immunol       Date:  2011-06       Impact factor: 4.330

8.  Human normal immunoglobulin in the treatment of primary immunodeficiency diseases.

Authors:  Philip Wood
Journal:  Ther Clin Risk Manag       Date:  2012-04-02       Impact factor: 2.423

9.  Subcutaneous immunoglobulin therapy: a new option for patients with primary immunodeficiency diseases.

Authors:  Lisa Kobrynski
Journal:  Biologics       Date:  2012-08-24

10.  Effectiveness of low-dose intravenous immunoglobulin therapy in minor primary antibody deficiencies: A 2-year real-life experience.

Authors:  Emanuele Vivarelli; Andrea Matucci; Susanna Bormioli; Paola Parronchi; Francesco Liotta; Lorenzo Cosmi; Fabio Almerigogna; Alessandra Vultaggio
Journal:  Clin Exp Immunol       Date:  2021-06-28       Impact factor: 5.732
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.